
Shire has seen an application for its dry eye treatment lifitegrast rejected by the US regulator. The FDA says it …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

